Tamr raises $21 million to expand agentic data management
Oct 14, 2026
Funding
Tempus Acquires Paige to Enhance Digital Pathology Capabilities
Aug 25, 2025
Tempus has acquired Paige for $81.25 million, expanding its digital pathology capabilities with Paige's extensive AI applications and datasets.
Tempus has announced the acquisition of Paige.AI, a leader in digital pathology, for $81.25 million, as stated in a press release. This acquisition allows Tempus to expand its dataset and technical team, strengthening its position in digital pathology with Paige's industry-leading technology portfolio.
Founded in 2017, Paige has developed several AI applications, including the first FDA-cleared AI application in pathology, which aids in cancer detection. Paige's proprietary dataset includes nearly 7 million digitized pathology slides, providing a robust foundation for advancing cancer research and drug development.
The acquisition is expected to accelerate Tempus's efforts in building a comprehensive foundation model in oncology, leveraging Paige's extensive dataset and expertise in generative AI. The transaction is primarily financed through Tempus common stock, along with the assumption of Paige's existing commitments under its Microsoft Azure cloud services agreement.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Sep 24, 2026
Funding
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Oct 12, 2026
Biotech
HR Path Acquires SnapAI for AI Compliance Expertise
Oct 12, 2026
Acquisitions
Sopris Capital Acquires Blackford Analysis from Bayer
Oct 12, 2026
Acquisitions
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Sep 19, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.